Corvus Pharmaceuticals

+$0.04 (+1.63%) Today
-$0.04 (-1.60%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRVS and other stocks, options, and ETFs commission-free!

About CRVS

Corvus Pharmaceuticals, Inc. Common Stock, also called Corvus Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies.

CEO
Richard A. Miller
Employees
42
Headquarters
Burlingame, California
Founded
2014

CRVS Key Statistics

Market Cap
98.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
854.94K
High Today
$2.56
Low Today
$2.45
Open Price
$2.50
Volume
244.62K
52 Week High
$6.88
52 Week Low
$2.45

CRVS Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, After Hours

You May Also Like

ASPCU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure